SPARC Upswing After Licensing Drug Rights to Visiox Pharma
Summary : SPARC has entered into an agreement with Visiox Pharma to grant exclusive worldwide rights for the development and commercialization of…
Summary : SPARC has entered into an agreement with Visiox Pharma to grant exclusive worldwide rights for the development and commercialization of…
Australian biotech giant CSL is negotiating with Vifor Pharma Group to acquire the Swiss company for A$10 billion ($7.1 billion), says the…
Synopsis : SPARC enters agreement with Biomodifying to gain rights on antibody to treat cancer Sun Pharma Advanced Research Company (SPARC) gained…